Non-valvular Atrial Fibrillation Clinical Trials

70 clinical trials for Non-valvular Atrial Fibrillation across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• WATCHMAN FLX Pro European Registry — RECRUITING · NA
• Precision Antithrombotic Therapy — RECRUITING
• FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients — RECRUITING · NA
• Applause Study I - Append System Early Feasibility Study — RECRUITING · NA
• Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding — RECRUITING
• Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion — RECRUITING
• Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation — RECRUITING · PHASE4
• Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events — RECRUITING
• dabigatran and rivaroxaban: prediction of anticoagulant effect — ACTIVE_NOT_RECRUITING · PHASE4
• Amplatzer Amulet China Post Market Study (PMS) — TERMINATED
• Population Pharmacokinetics of Apixaban in Asian Patients With Atrial Fibrillation — NOT_YET_RECRUITING
• A randomised active-controlled trial to assess the safety and pharmacodynamics of two blinded doses of vortosiran and open-label apixaban in patients with non-valvular atrial fibrillation — NOT_YET_RECRUITING · PHASE2
• An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation — ACTIVE_NOT_RECRUITING · NA
• A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination — SUSPENDED · NA
• A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation — COMPLETED
• Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF) — NOT_YET_RECRUITING · NA
• Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation — COMPLETED · PHASE4
• LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation — NOT_YET_RECRUITING · NA
• The CONFORMAL Early Feasibility Study — ACTIVE_NOT_RECRUITING · NA
• A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke — NOT_YET_RECRUITING · NA
• Watchman FLX Pro CT Pilot Study — COMPLETED · NA
• Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk — ACTIVE_NOT_RECRUITING · NA
• Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation — COMPLETED
• Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China — COMPLETED
• A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF) — COMPLETED
• To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers — ACTIVE_NOT_RECRUITING · PHASE1
• The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis — COMPLETED
• Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment — COMPLETED
• The Conformal Prague Study — COMPLETED · NA
• Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong — COMPLETED
• Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban — TERMINATED · NA
• Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding — COMPLETED
• Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data — COMPLETED
• WAVECREST Post Market Clinical Follow-Up (PMCF) Study — TERMINATED · NA
• Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation — COMPLETED
• Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function — COMPLETED
• Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation — OTHER · NA
• A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin — COMPLETED
• Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention — COMPLETED
• Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm — COMPLETED · NA
• Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) — OTHER · PHASE4
• Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation — COMPLETED
• Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry — COMPLETED
• Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF) — WITHDRAWN
• AMPLATZER™ Cardiac Plug Observational Post-Approval Study — COMPLETED
• LAMax Vs. Watchman LAAC Device for Subjects With Non-valvular AF to Reduce the Risk of Stroke — COMPLETED · NA
• Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI — COMPLETED
• Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center — COMPLETED
• A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention. — COMPLETED
• A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan — COMPLETED

Refine this search